齐鲁晚报·齐鲁壹点记者 田佳玉 苗润鹏 清晨，在威海文登泽库镇的参田里，几台农用收割机正轰鸣着穿梭作业。随着机器的不停转动，大片黑 褐色的西洋参破土而出，被翻至地表，在晨光里泛着光泽。近50位工人紧随其后弯腰忙碌，徒手将这些 带着湿润泥土气息的西洋参逐一捡拾，饱满的参体、密集的芦头尽显优质品相。从1981年试种的8棵参 苗艰难起步，到如今文登西洋参占据国内总产量近60%、世界总产量30%，"文登西洋参"品牌价值突破 百亿元，这片北纬37°的沃土，孕育出了"中国西洋参之都"的辉煌传奇。 8粒种子点燃希望 时光回溯到上世纪70年代末，文登口子李村还是一个靠300多亩薄地谋生的贫困村，46户村民人均年收 入仅20多元。22岁的退伍军人王文水看着乡亲们的贫困处境，决心寻找一条致富出路。在跟随村里老药 农王继振学习中草药种植后，他将希望寄托在了西洋参这一原产于北美洲的珍贵药材上。 1981年4月，山东省药材公司送来的11粒西洋参种子，成为了改变村庄命运的"希望火种"。王文水和王 继振当天便将种子小心翼翼地种在双顶山上，在旁边搭起草棚日夜看守，每两小时记录一次气温、光 照、湿度，生怕错过种子生长的任何细节。5月20日，当 ...

Overview of Operating Performance - The company reported a total revenue of 268 million yuan for 2024, a year-on-year decrease of 1.01% [1] - The net profit attributable to shareholders was 50.39 million yuan, down 21.7% year-on-year [1] - The net profit after deducting non-recurring gains and losses was 45.39 million yuan, a decline of 24.5% year-on-year [1] - In Q4, the total revenue was 51.45 million yuan, a decrease of 5.23% year-on-year, while the net profit increased by 122.88% to 12.61 million yuan [1] Financial Indicators Analysis - The main products include Huangqi Shengmai Drink, Western Ginseng Oral Liquid, and Shenjindan Capsules, with Huangqi Shengmai Drink contributing 73.32% of main revenue at 196 million yuan and a gross margin of 34.13% [2] - Western Ginseng Oral Liquid accounted for 15.17% of main revenue at 40.60 million yuan, with a gross margin of 37.46% [2] - Shenjindan Capsules contributed 8.76% of main revenue at 23.45 million yuan, with a gross margin of 37.13% [2] Operating Situation Review - The company faced challenges in 2024, with declines in both total revenue and net profit [3] - However, the significant growth in net profit during Q4 indicates signs of recovery [3] - Huangqi Shengmai Drink remains the dominant product, while other products showed relatively weak performance [3] Future Development Outlook - The company will continue to focus on the pharmaceutical sector, particularly in traditional Chinese medicine, and will actively respond to national policies [4] - Plans include strengthening existing sales channels and exploring new ones to enhance marketing effectiveness [4] - The company aims to improve operational management to address industry policy changes and market competition pressures [4] Key Financial Metrics - Gross margin was 33.83%, down 18.04% year-on-year [6] - Net margin was 18.83%, a decrease of 20.9% year-on-year [6] - Earnings per share were 0.31 yuan, down 22.5% year-on-year [6] - Operating cash flow per share increased by 0.27% to 0.33 yuan [6] - Cash and cash equivalents totaled 503 million yuan, down 7.45% year-on-year [6] - Accounts receivable increased by 18.14% to 11.80 million yuan [6]